Optic Nerve Sheath Diameter for Prediction of Outcome After Cardiac Arrest
ONSD-CA
The Optic Nerve Sheath Diameter for Prediction of Outcome After Cardiac Arrest: a Pilot Prospective Study
1 other identifier
observational
36
0 countries
N/A
Brief Summary
Early prognostication in resuscitated cardiac arrest (CA) patients, within the first day after admission in the intensive care unit (ICU), remains difficult. Optic nerve sheath diameter (ONSD) measurement could predict increased intracranial pressure. Preliminary works showed that ONSD measurement could be used to predict outcome in post-CA patients. The aim of this study was to assess the ability of bedside ONSD ultrasonographic measurement to predict survival and Cerebral Performance Category (CPC) score at hospital discharge in post-cardiac arrest patients treated with therapeutic hypothermia (TH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2011
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 24, 2015
CompletedFirst Posted
Study publicly available on registry
July 31, 2015
CompletedJuly 31, 2015
July 1, 2015
1.8 years
July 24, 2015
July 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In-hospital mortality
participants will be followed for the duration of hospital stay, an expected average of 3 months.
3 months
Eligibility Criteria
All unconscious (Glasgow Coma Scale ≤6) patients ≥18 years old, admitted in ICU after successful resuscitation from CA, and treated with TH targeted to 33°C were screened. Exclusion criteria were as follows: unavailable ONSD measurement within 24 hours after return of spontaneous circulation (unavailable investigator, early death, or major hemodynamic instability), traumatic or neurological origin of CA, previous cerebrovascular disease, facial trauma affecting the orbits and/or eyeballs, and previous history of ocular pathology such as exophthalmia, glaucoma or cataract.
You may qualify if:
- Unconscious (Glasgow Coma Scale ≤6)
- ≥18 years old
- Admitted in ICU after successful resuscitation from CA
- Treated with TH targeted to 33°C
You may not qualify if:
- unavailable ONSD measurement within 24 hours after return of spontaneous circulation (unavailable investigator, early death, or major hemodynamic instability)
- Traumatic or neurological origin of CA
- Previous cerebrovascular disease
- Facial trauma affecting the orbits and/or eyeballs
- Previous history of ocular pathology such as exophthalmia, glaucoma or cataract.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital of Melunlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 24, 2015
First Posted
July 31, 2015
Study Start
November 1, 2011
Primary Completion
September 1, 2013
Study Completion
January 1, 2014
Last Updated
July 31, 2015
Record last verified: 2015-07